David j birnkrant (9 résultats)

Paperback. Etat : new. Paperback. Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: A New Approach for Clinicians, Researchers and Regulators Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Etat : New. 2026. 1st Edition. paperback. . . . . .

Etat : New. Advances the delivery of cardiorespiratory-focused care for individuals with DMDIdentifies potential flaws in current DMD drug study methodologies and recommends key improvementsExamines problems with the current DMD drug approval .

Paperback. Etat : new. Paperback. Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: A New Approach for Clinicians, Researchers and Regulators Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Paperback. Etat : Brand New. 200 pages. 8.50x0.47x10.87 inches. In Stock.

Etat : New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.…

Etat : New. 2026. 1st Edition. paperback. . . . . . Books ship from the US and Ireland.

Taschenbuch. Etat : Neu. Neuware - Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: New Perspectives and Controversies is designed to address key challenges in the field by providing a cardiorespiratory perspective on clinical care, drug development, and the regulatory approval of new drugs. The book discusses current achievements and limitations of care and addresses clinical challenges. It offers a detailed, critical examination of the drug development process and identifies potential flaws in current regulatory processes. Novel recommendations for improving study methodologies and regulatory decisions are discussed, with the goal of enabling more effective drugs to reach individuals with Duchenne Muscular Dystrophy (DMD).This book is designed to provide important and interesting information to a variety of stakeholders, including clinicians, researchers, and regulators, as well as patients and their caregivers. Clinicians will find a summary of standards of care and strategies to overcome the challenges they are likely to face in enacting those standards. Researchers will gain insights into the crucial importance of cardiorespiratory outcome measures and find recommendations designed to improve study methodologies. Regulators will benefit from an examination of potential flaws in the current drug approval process and from proposed recommendations aimed at ensuring that approved drugs are truly effective. The goal of this comprehensive approach is to enhance the outcomes and survival of individuals with DMD by focusing on key determinants of cardiorespiratory health.…

Paperback. Etat : new. Paperback. Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: A New Approach for Clinicians, Researchers and Regulators Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.